International Conference on Arrhythmia and Electrophysiology


18 – 19th January 2019

"Dear friends and colleagues,


thank you very much again for your involvement in the 12th EMB. Once again, you made EMB 2019 a vibrant forum, providing leading expertise on a broad and versatile range of perspectives and ideas. This will no doubt resonate with our ongoing work. The great success of this year’s meeting encourages us also to making #EMB2020 as exciting and fascinating as this year’s. We look forward to seeing you again in Berlin next year."


Roberto Belke

Managing Director Central, Northern, South Eastern Europe

EMB #12


For the 12th straight year, Expert Meeting Berlin (EMB) is committed to the sharing of best practice between cardiologists and electrophysiologists from around the globe. Physicians will gather in Berlin to share their practical expertise, latest insights into new device technologies and forge scientific relationships during the two-day meeting. This year's featured topics include recent scientific developments in ventricular and atrial arrhythmia management, including patient-tailored heart failure (HF) therapy concepts and evolving eHealth solutions for multidisciplinary care. Further, this year’s EMB has a special focus on digital health applications and advantages through artificial intelligence in medicine.



  • Ventricular Arrhythmia & Heart Failure Management: Latest Insights
  • Diagnosis & Therapy of Atrial Fibrillation: From Pharmacological Treatment to Strategies Tailored to Disease Progression and Patient Characteristics
  • New Tools & Technologies: Cardiac Devices and eHealth Solutions


EMB Program



Since 2006, renowned cardiologists and electrophysiologists from various countries meet annually in the heart of Berlin discussing latest findings on pioneering technologies in diagnostic and therapeutic methods referred to cardiac rhythm management. The intention of the EMB is to spearhead collaborative efforts by experts in academia, clinical practice and industry to accelerate development of practical technology for treating, monitoring, diagnosing and preventing complications from arrhythmia. Bringing together international expertise on a regular base it enables physicians to benefit from the eclectic experiences and ideas of the best in their fields allowing them to return to work inspired and ready to tackle new challenges.


The EMB program includes in‐depth exploration of new advances in the mechanisms of atrial and ventricular arrhythmias, heart failure management and cutting edge treatments for patients diagnosed with cardiac diseases. Divided into two days, the EMB is designed to meet individual preferences, to share knowledge and promote effective management of cardiac arrhythmias. Lectures, case presentations and panel discussions will be utilized to share overall practical knowledge.



  • Bulava, Alan I Ceske Budejovice, Czech Republic
  • Campbell, Kevin I Raleigh, USA
  • Cochét, Hubert I Bordeaux, France
  • Halbfaß, Philip I Bad Neustadt, Germany
  • Häusler, Karl Georg I Würzburg, Germany
  • Haverkamp, Wilhelm I Berlin, Germany
  • Hindricks, Gerhard I Leipzig, Germany
  • Jung, Werner | Villingen-Schwennigen, Germany
  • Kautzner, Josef I Prague, Czech Republic
  • Köhler, Friedrich I Berlin, Germany
  • Kottkamp, Hans I Zurich, Switzerland
  • Lewalter, Thorsten I Munich, Germany
  • Michael, Kevin I Pietermaritzburg, South Africa
  • Peichl, Petr I Prague, Czech Republic
  • Raake, Philip I Heidelberg, Germany
  • Richter, Utz I Dresden, Germany
  • Sack, Stefan I Munich, Germany
  • Sommer, Philipp I Bad Oeynhausen, Germany
  • Willems, Stephan I Hamburg, Germany

Scientific Board

  • Bänsch, Dietmar I Güstrow, Germany
  • Deneke, Thomas I Bad Neustadt, Germany
  • Piorkowski, Christopher I Dresden, Germany
  • Schumacher, Burghard I Kaiserslautern, Germany


  • Böcker, Dirk I Hamm, Germany
  • Chun, Julian I Frankfurt, Germany
  • Jung, Werner I Villingen-Schwennigen, Germany
  • Merkely, Béla I Budapest, Hungary







  •   9.00 - 9.45             New Devices and Technologies (Part 2) | Chair : C. Piorkowski and J. Chun

    09.00 – 09.20


    09.25 – 09.45

    Digital health in cardiology: Patients, biosensors, clinical care I G. Hindricks


    Leadless pacemaker: Current data and stage of development I W. Jung

  •   9.50 - 12.10             AF Therapy | Chair : D. Bänsch and B. Merkely

    09.50 – 10.10


    10.15 – 10.35





    11.00 – 11.20


    11.25 – 11.45


    11.50 – 12.10



    Learnings from terminated RCTs in ESUS patients with prophylactic NOAC treatment I K. G. Häusler


    Patient selection for AF- ablation and impact of risk factor management on  treatment success. How can the patient contribute?

    Lifestyle modifications and outcome of AF ablation I H. Kottkamp


    Coffee break


    What is the benefit of AF ablation beyond complete AF elimination? I K. Michael


    Temperature-controlled RF-ablation forpulmonary vein isolation in patients with AF I J. Kautzner


    What do randomized mortality studies on AF ablation tell us? I P. Sommer


    Summary & farewell



Manuela Brown

Executive Assistant to Roberto Belke

BIOTRONIK Vertriebs GmbH & Co. KG

Woermannkehre 1 I 12359 Berlin, Germany



        + 49 (3) 68905 1511

        + 49 151 6890 1511

Meeting Location

Radisson Blu Hotel

Karl-Liebknecht-Straße 3

10178 Berlin

+49 30 23828–0











The meeting is organized and supported by BIOTRONIK, a leading medical device company that has been developing cardiovascular and endovascular solutions for more than 50 years. Driven by the purpose to perfectly match technology with the human body, BIOTRONIK products deliver care that saves and improves the lives of millions diagnosed with heart or blood vessel diseases every year.


BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.


International Conference on Arrhythmia & Electrophysiology